Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -2.167\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) COc1ccc(C(=O)Nc2ccc3c(c2)nc2n3CCSC2)cc1
(b) CCCNC(=O)COc1cccc(C(=O)NCc2ccccc2)c1
(c) Cc1cc(C(F)(F)F)nc(SCC(=O)NC2CC3CCC2C3)n1
Answer: c. Cc1cc(C(F)(F)F)nc(SCC(=O)NC2CC3CCC2C3)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C(F)(F)F)nc(SCC(=O)NC2CC3CCC2C3)n1
Cc1cc(C(F)(F)F)nc(SCC(=O)NC2CC3CCC2C3)n1
N-(2-bicyclo[2.2.1]heptanyl)-2-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylacetamide